K

KYMR

Kymera Therapeutics, Inc.

33.58

-1.70-4.82%
After Hours: 33.58  0.00  0.00%16:44 05/05 EDT

Financial Statements

Statement:

Key indicator

Income Statement

Balance Sheet

Cash Flow

Reporting Period:

Accumulated Report

FY

YoY:
FY: Financial Year Annual Report
Q: Quarter is quarterly reports. Q1, Q2, Q3 and Q4 are reports for a single quarter. Q6 and Q9 are accumulated quarterly reports, respectively contain 6 months' reports and 9 months' report.
Item
FY 2024
FY 2023
FY 2022
FY 2021
FY 2020
Total Revenue

47.07M

78.59M

46.83M

72.83M

34.03M

Revenue

47.07M

78.59M

46.83M

72.83M

34.03M

Other Revenue, Total

--

--

--

--

--

Cost of Revenue, Total

--

--

--

--

--

Gross Profit

--

--

--

--

--

Operating Expense

308.71M

244.12M

208.08M

173.36M

80.34M

Selling/General/Admin.Expenses,Total

63.53M

55.04M

43.83M

36.34M

18.23M

Research & Development

240.25M

189.08M

164.25M

137.02M

62.10M

Depreciation/Amortization

--

--

--

--

--

Interest Exp.(Inc.), Net-Operating, Total

--

--

--

--

--

Unusual Expense (Income)

4.92M

--

--

--

--

Other Operating Expenses, Total

--

--

--

--

--

Operating Income

-261.63M

-165.53M

-161.26M

-100.53M

-46.30M

Interest Inc.(Exp.),Net-Non-Op.,Total

37.78M

18.57M

6.45M

313.00K

711.00K

Gain(Loss) on Sale of Assets

--

--

--

--

--

Other, Net

--

--

--

--

--

Net Income Before Taxes

-223.86M

-146.96M

-154.81M

-100.22M

-45.59M

Provision for Income Taxes

--

--

--

--

--

Net Income After Taxes

-223.86M

-146.96M

-154.81M

-100.22M

-45.59M

Minority Interest

--

--

--

--

--

Equity in Affiliates

--

--

--

--

--

U.S. GAAP Adjustment

--

--

--

--

--

Net Income Before Extra. Items

-223.86M

-146.96M

-154.81M

-100.22M

-45.59M

Total Extraordinary Items

--

--

--

--

--

Net Income

-223.86M

-146.96M

-154.81M

-100.22M

-45.59M

Total Adjustments to Net Income

--

--

--

0

-9.05M

Income Available to Com Excl ExtraOrd

-223.86M

-146.96M

-154.81M

-100.22M

-54.64M

Income Available to Com Incl ExtraOrd

-223.86M

-146.96M

-154.81M

-100.22M

-54.64M

Dilution Adjustment

--

--

--

--

--

Diluted Net Income

-223.86M

-146.96M

-154.81M

-100.22M

-54.64M

Diluted Weighted Average Shares

75.04M

58.37M

53.93M

47.99M

44.48M

Diluted EPS Excluding ExtraOrd Items

-2.98302

-2.51796

-2.87036

-2.08833

-1.22842

Diluted EPS including ExtraOrd Items

-2.983024

-2.51796

-2.870364

-2.088332

-1.228424

DPS – Common Stock Primary Issue

--

--

--

--

0

Diluted Normalized EPS

-2.9174

-2.51796

-2.87036

-2.08833

-1.22842